EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Ionized and total magnesium levels in patients with chronic kidney disease: associated factors and outcomes

Maxime Pluquet, Said Kamel, Natalia Alencar de Pinho iD, Nicolas Mansencal iD, Christian Combe iD, Marie Metzger, Ziad A Massy iD, Sophie Liabeuf iD, Solène M Laville iD

Clinical Kidney Journal · 01.04.2024 · 17 (4)

DOI: 10.1093/ckj/sfae046 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Kidney Journal, online erschienen am 23.02.2024. Verfasst von Maxime Pluquet und 8 weiteren Autor:innen. Beteiligte Einrichtung: MP3CV Laboratory, Jules Verne University of Picardie, Amiens, France. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Fondation du Rein, Fondation pour la Recherche Médicale.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The association between hypo- and/or hypermagnesaemia and cardiovascular (CV) outcomes or mortality has shown conflicting results in chronic kidney disease (CKD) and has been conducted on total magnesium (tMg) levels. Thus, the objectives of the present study were to (i) describe the serum ionized Mg (iMg) concentration in patients at various CKD stages, (ii) measure the correlation between iMg and tMg concentrations, (iii) identify their associated factors and (iv) determine whether serum tMg and/or iMg concentrations are associated with major adverse cardiovascular events (MACE) and mortality before kidney replacement therapy in CKD patients.

Methods

Chronic Kidney Disease–Renal Epidemiology and Information Network (CKD-REIN) is a prospective cohort of CKD patients with an estimated glomerular filtration rate (eGFR) <60 mL/min/1.73 m2. Baseline iMg and tMg serum concentrations were centrally measured. Adjusted cause-specific Cox proportional hazard models were used to estimate hazard ratios (HRs) for first MACE and for mortality.

Results

Of the 2419 included patients, median age was 68 years, and the mean eGFR was 34.8 mL/min/1.73 m2. Concentrations of serum iMg and tMg were strongly correlated (r = 0.89, P < .001) and were independently associated with eGFR. The adjusted HR [95% confidence interval (CI)] for MACE associated with the baseline serum tMg level was 1.27 (0.95; 1.69) for patients in Tertile 1 and 1.56 (1.18; 2.06) for patients in Tertile 3, relative to patients in Tertile 2. The HR (95% CI) of death according to serum tMg concentration was increased in Tertile 3 [1.48 (1.11; 1.97)]. The adjusted risk for MACE and mortality (all-cause or CV) associated with the baseline serum iMg level was not significantly different between tertiles.

Conclusions

Our analysis of a large cohort of patients with moderate-to-advanced CKD demonstrated that individuals with higher serum tMg concentrations, although still within the normal range, had a greater likelihood of MACE and mortality. However, serum iMg levels were not associated with these outcomes.

Schlagwörter

Stichwörter der Autor:innen

cardiovascular diseasechronic kidney diseasemagnesiummortality

Autor:innen und Institutionen

  • MP3CV Laboratory, Jules Verne University of Picardie, Amiens, France.
  • Department of Biochemistry, Amiens-Picardie University Medical Center, Amiens, France.
  • Centre for Research in Epidemiology and Population Health (CESP), INSERM UMRS 1018, Université Paris-Saclay, Université Versailles Saint Quentin, Villejuif, France.
  • Department of Cardiology, Ambroise Paré University Hospital, APHP, Boulogne-Billancourt, Paris, France.
  • Service de Néphrologie Transplantation Dialyse Aphérèse, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.
  • INSERM, U1026, Univ Bordeaux Segalen, Bordeaux, France.

ORCID-Profile: Natalia Alencar de Pinho, Nicolas Mansencal, Christian Combe, Ziad A Massy, Sophie Liabeuf, Solène M Laville

Förderung

  • Fondation du Rein
  • Fondation pour la Recherche Médicale

Zitieren

APA

Pluquet, M., Kamel, S., Alencar de Pinho, N., Mansencal, N., Combe, C., Metzger, M., Massy, Z. A., Liabeuf, S., & Laville, S. M. (2024). Ionized and total magnesium levels in patients with chronic kidney disease: associated factors and outcomes. Clinical Kidney Journal, 17(4). https://doi.org/10.1093/ckj/sfae046

Vancouver

Pluquet M, Kamel S, Alencar de Pinho N, Mansencal N, Combe C, Metzger M, et al. Ionized and total magnesium levels in patients with chronic kidney disease: associated factors and outcomes. Clinical Kidney Journal. 2024;17(4). doi:10.1093/ckj/sfae046

BibTeX
@article{Pluquet2024,
  author = {Pluquet, Maxime and Kamel, Said and Alencar de Pinho, Natalia and Mansencal, Nicolas and Combe, Christian and Metzger, Marie and Massy, Ziad A and Liabeuf, Sophie and Laville, Solène M},
  title = {Ionized and total magnesium levels in patients with chronic kidney disease: associated factors and outcomes},
  journal = {Clinical Kidney Journal},
  year = {2024},
  volume = {17},
  number = {4},
  doi = {10.1093/ckj/sfae046}
}
Kostenlos starten →